Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.

The Journal of urology - 1 Dec 1998

Ye D, Li H, Qian S, Sun Y, Zheng J, Ma Y

Abstract excerpt

PURPOSE: Studies have shown that the effects of chemotherapy depend on some biochemical mechanisms to induce apoptosis. Many genes are involved in apoptosis modulation, including p53, bcl-2 and bax. We determined the roles of p53 status and the ratio of bcl-2/bax proteins for predicting the recurrence of bladder superficial transitional cell carcinoma that had been treated with intravesical chemotherapy after...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-bcl-2

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 9817315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.PMID 9817315Read ↗

bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancerSemantic proximity Read ↗

The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.Semantic proximity Read ↗

p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder.Semantic proximity Read ↗

Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.Semantic proximity Read ↗

Synergistic enhancement of resistance to cisplatin in human bladder cancer cells by overexpression of mutant-type p53 and Bcl-2.Semantic proximity Read ↗

Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection.Semantic proximity Read ↗

MVAC chemotherapy-induced apoptosis and p53 alterations in the rat model of bladder cancer.Semantic proximity Read ↗

p53 gene mutation in recurrent superficial bladder cancer.Semantic proximity Read ↗

P53 mutation predicts intravesical adriamycin instillation failure in superficial transitional cell carcinoma of bladder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.